Trials / Unknown
UnknownNCT05281029
Observational Study Gemigliptin in Patients Aged ≥ 65 Years With Type 2 Diabetes Mellitus
A Multicenter, Single-arm, Prospective Observational Study to Evaluate the Safety and Effectiveness of Gemigliptin (as Monotherapy or as Single Pill Combinations) in Patients Aged ≥ 65 Years With Type 2 Diabetes Mellitus
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- LG Chem · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate safety and effectiveness of treatment with gemigliptin for 24 weeks in Korean patients aged ≥ 65 years with type 2 diabetes mellitus in routine clinical settings
Conditions
Timeline
- Start date
- 2021-06-24
- Primary completion
- 2023-10-31
- Completion
- 2023-10-31
- First posted
- 2022-03-15
- Last updated
- 2022-03-16
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05281029. Inclusion in this directory is not an endorsement.